BANCO SANT ANDER BRASIL SA — Metoprolol Importer Profile
Pharmaceutical Importer · #9 buyer for Metoprolol · $5.0M import value · 146 shipments · BRAZIL · DGFT Verified
BANCO SANT ANDER BRASIL SA is the #9 importer of Metoprolol from India with $5.0M in import value and 146 verified shipments. BANCO SANT ANDER BRASIL SA holds a 1.3% market share in Metoprolol imports based in BRAZIL. The company sources from 2 verified suppliers across 31 formulations shipped to 1 country.
BANCO SANT ANDER BRASIL SA — Metoprolol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Metoprolol to BANCO SANT ANDER BRASIL SA?
Verified from 146 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $4.3M | 130 | 87.6% |
| DR REDDY S LABORATORIES LIMITED | $614.4K | 16 | 12.4% |
BANCO SANT ANDER BRASIL SA sources Metoprolol from 2 verified Indian suppliers based on 146 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 87.6% of imports.
How Does BANCO SANT ANDER BRASIL SA Compare to Nearest Metoprolol Importers?
Buyers ranked immediately above and below #9 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | UNITED STATES | $12.6M | 252 | $50.0K |
| 6 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $11.1M | 221 | $50.0K |
| 9 | BANCO SANT ANDER BRASIL SA ★ | BRAZIL | $6.5M | 146 | $44.4K |
| 10 | NORTHSTAR DISTRIBUTION CENTER 8912 | UNITED STATES | $6.3M | 191 | $32.9K |
| 11 | EVERSANA LIFE SCIENCE SERVICES LLC- | UNITED STATES | $6.0M | 193 | $31.2K |
BANCO SANT ANDER BRASIL SA ranks #9 among 949 Metoprolol importers from India. Average shipment value of $44.4K compared to the market average of $102.1K. The closest competitors by value are CIPLA USA INC UPS SUPPLY CHAIN SOLU and DR. REDDYS LABORATORIES, INC.
Where Does BANCO SANT ANDER BRASIL SA Import Metoprolol To?
Destination countries from 146 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $5.0M | 146 | 100.0% |
BANCO SANT ANDER BRASIL SA imports Metoprolol to 1 country. The primary destination is BRAZIL receiving 100.0% of shipments worth $5.0M.
What Metoprolol Formulations Does BANCO SANT ANDER BRASIL SA Import?
| Formulation | Value | Shipments |
|---|---|---|
| Succinato de metoprolol 50mg (30's Pack) | $999.9K | 21 |
| Succinato de metoprolol 25mg (30's Pack) | $347.6K | 11 |
| SUCCINATO DE METOPROLOL 25MG(30'S PACK) | $288.6K | 9 |
| SUCCINATO DE METOPROLOL 25 MG (30S PACK) | $266.1K | 6 |
| SUCCINATO DE METOPROLOL 50MG | $250.0K | 5 |
| SUCCINATO DE METOPROLOL 50 MG (30S PACKS)NOS | $228.4K | 12 |
| Succinato de metoprolol 100mg (30's Pack) | $201.5K | 6 |
| Succinato de metoprolol 25MG 30 s Pack | $191.5K | 6 |
| Succinato de metoprolol 50mg (30's Pack)(300037182 ) | $188.8K | 4 |
| Succinato de metoprolol 50MG 30 s Pack | $188.4K | 5 |
BANCO SANT ANDER BRASIL SA imports 31 distinct Metoprolol formulations from India. The top formulation is Succinato de metoprolol 50mg (30's Pack) with 21 shipments worth $999.9K.
Regulatory Requirements: Importing Metoprolol into Brazil
What BANCO SANT ANDER BRASIL SA and other importers must comply with to import Metoprolol from India
Regulatory Authority
Brazilian Health Regulatory Agency (ANVISA)
Approval Process for Generic Metoprolol
Generic drug registration under RDC 200/2017. Requires pharmaceutical equivalence and bioequivalence studies. ANVISA GMP inspection of overseas facilities mandatory.
Typical timeline: 12–24 months
GMP Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Import Licence & Documentation
Import Authorization (LI) via SISCOMEX; Sanitary Import Permit from ANVISA
Labeling & Packaging
Portuguese language labeling mandatory; ANVISA registration number
Note: ANVISA maintains an active inspection program for Indian pharma facilities. Inspection backlog can extend timelines significantly.
Regulatory information is provided for general reference based on publicly available ANVISA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with ANVISA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Metoprolol from India and How Much Does BANCO SANT ANDER BRASIL SA Import?
India exported $96.9M worth of Metoprolol through 10,118 shipments from 306 suppliers to 118 countries, serving 949 buyers globally. BANCO SANT ANDER BRASIL SA imports $5.0M of this total, accounting for 1.3% of India's Metoprolol exports with 146 shipments from BRAZIL. This is verified from 146 customs shipment records covering 31 distinct formulations.
What Is the Average Order Value for BANCO SANT ANDER BRASIL SA's Metoprolol Imports?
BANCO SANT ANDER BRASIL SA's average Metoprolol order value is $34.0K per consignment, based on 146 shipments totaling $5.0M. BANCO SANT ANDER BRASIL SA is based in BRAZIL and ranks #9 among all Metoprolol importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Metoprolol to BANCO SANT ANDER BRASIL SA?
BANCO SANT ANDER BRASIL SA sources Metoprolol from 2 verified Indian suppliers: DR.REDDY'S LABORATORIES LIMITED ($4.3M, 87.6%), DR REDDY S LABORATORIES LIMITED ($614.4K, 12.4%). This is based on 146 customs records.
How Does BANCO SANT ANDER BRASIL SA Compare to Other Metoprolol Importers?
BANCO SANT ANDER BRASIL SA ranks #9 among 949 Metoprolol importers from India with a 1.3% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES LLC ($16.3M), CIPLA USA INC UPS SUPPLY CHAIN SOLU ($12.6M), DR. REDDYS LABORATORIES, INC ($11.1M). BANCO SANT ANDER BRASIL SA processed 146 shipments from BRAZIL.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Metoprolol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Metoprolol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BANCO SANT ANDER BRASIL SA matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BANCO SANT ANDER BRASIL SA's capped import value divided by total capped export value for Metoprolol across all Indian exporters.
- 5.Verified Records: This page is backed by 146 individual customs records matching BANCO SANT ANDER BRASIL SA importing Metoprolol, covering 31 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 118+ countries, 949+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Metoprolol Import Data for BANCO SANT ANDER BRASIL SA
Access order-level details, pricing data, supplier connections, and competitive analysis for BANCO SANT ANDER BRASIL SA's Metoprolol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BANCO SANT ANDER BRASIL SA
Company Profile
Multiple products · $0 total trade · Multiple categories
BANCO SANT ANDER BRASIL SA × Metoprolol
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BANCO SANT ANDER BRASIL SA.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Metoprolol. For current order-level data, contact TransData Nexus.